Anifrolumab to Treat Severe Hepatic Involvement in a De Novo IFIH1 Mutation

J Clin Immunol. 2026 Apr 6;46(1):41. doi: 10.1007/s10875-026-01981-8.

NO ABSTRACT

PMID:41941034 | DOI:10.1007/s10875-026-01981-8